Thromboembolism in Anorexia Nervosa
Key facts
- Who runs it
- Odense University Hospital
- Where
- Denmark and Sweden5 sites in 2 countriesChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 80 people enrolled
- Started
- 15 Nov 2022
- Ended
- 10 Oct 2024
- Type of study
- Observational, 2 groups
- Treatments tested
- Blood samples
- Questionnaires
- Record updated
- 15 October 2024
Who can take part
- Age
- 18 years to 50 years
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Fulfilling Diagnostic and Statistical Manual V (DSM-5) criteria for AN
- Age 18 - 50 years
- Female sex
- BMI 18.5 - 25.0
- Age 18 - 50 years
- Female sex
Who cannot take part
- Somatic comorbidity requiring systemic medications
- Previous thromboembolic event and/or known genetic predisposition
- Somatic comorbidity requiring systemic medications
- Previous thromboembolic event and/or known genetic predisposition
- Use of p.o. hormonal contraception
- Smoking
- Use of p.o. hormonal contraception
- Smoking
Where is this trial?
It has sites in 2 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
BACKGROUND: Sudden death due to thromboembolic (TE) events in patients with anorexia nervosa (AN) is well known. However, the incidence of TE events and the hemostatic balance in patients with AN are sparsely investigated. Also, associations between re-nutrition and the hemostatic balance have not been studied.
Read full original descriptionShow less
OBJECTIVE: To describe the incidence of TE events in patients with AN compared to the background population, to characterize the hemostatic balance in AN compared to normal-weight women, and to assess the associations between the hemostatic balance and nutritional status, insulin sensitivity and cortisol level in women with AN.
METHODS: The incidence of TE will be described using a Danish cohort of AN patients (n=10,049) with follow-up in national registries. A comprehensive battery of hemostatic biomarkers will be compared in a case-control study of 40 patients with AN and associations between hemostasis and nutritional status will be studied.
The 2 groups in the trial
- Patients
Will have thromboembolic incidence rate evaluated and will have a battery of hemostatic markers analyzed
Treatment: Blood samples and Questionnaires
- Controls
Will have thromboembolic incidence rate evaluated and will have a battery of hemostatic markers analyzed
Treatment: Blood samples
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Thromboembolism in Anorexia Nervosa: a Registry-based Study of a National Cohort and a Case-control Study of the Hemostatic Balance and Its Association with Nutritional Status, Insulin and Cortisol
- Record updated
- 15 October 2024